Pravachol ; Generic Name: pravastatin sodium ; Brand Name: Pravachol ; Drug Class: HMG-CoA Reductase Inhibitors, Lipid-Lowering Agents, Statins
the prescribing information of the entire class of statin medicines. These changes include removing the contraindication against using these medicines in all pregnant patients. A...
See full prescribing information for PRAVACHOL. PRAVACHOL (pravastatin sodium) Tablets Initial U.S. Approval: 1991 INDICATIONS AND USAGE PRAVACHOL is an HMG-CoA reductase inhibitor (statin)...
See full prescribing information for PRAVACHOL. PRAVACHOL (pravastatin sodium) Tablets Initial U.S. Approval: 1991 RECENT MAJOR CHANGES Dosage and Administration Patients with Renal...
Pravastatin is used together with diet to lower blood levels of "bad" cholesterol (low-density lipoprotein, or LDL), to increase levels of "good" cholesterol (high-density lipoprotein, or HDL), and to lower triglycerides (a type of fat in the blood). Pravastatin is also used to lower the risk of stroke, heart attack, and other heart complications in people with or without coronary heart disease or other risk factors. Pravastatin is used in adults and children who are at least 8 years old. ...
brief information about eltrombopag olamine and a collection of links to more information about the use of this drug, research results, and... MedlinePlus Information on Eltrombopag Olamine - A lay language...
They need to know if you have any of these conditions: Diabetes (high blood sugar) · If you often drink alcohol · Kidney disease · Liver disease · Muscle cramps, pain · Stroke · Thyroid disease · An unusual or allergic reaction to pravastatin, other medications, foods, dyes, or preservatives · Pregnant or trying to get pregnant · Breast-feeding
Adult ; May be beneficial for prophylaxis of cardiovascular events in at-risk patients, even if patients have normal levels of cholesterol. ; 10-40 mg PO qDay; not to exceed 80 mg/day ; Initiate with 10 mg qHS if taking immunosuppressants like cyclosporine concurrently; not to exceed 20 mg/day
Top drug rank, #37 ( 2 ) ; Estimated number of prescriptions in the United States (2022), 16,317,126 ; Estimated number of patients in the United States (2022), 3,949,800 ; Average total drug cost (USD), ; Per prescription, $27.83 ; Per day of therapy, $0.41/day ; Average out-of-pocket cost (USD), ; Per prescription, $5.24 ; Per day of therapy, $0.09/day
Antilipemic agent; hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor (i.e., statin). Adjunct to nondrug therapies (i.e., lifestyle modifications) in patients with hypercholesterolemia without clinical evidence of CHD to reduce the risk of MI, to reduce the risk of undergoing myocardial revascularization procedures, and to reduce the risk of cardiovascular mortality (with no increase in death from noncardiovascular causes). Adjunct to diet and lifestyle modifications in patients with clinic...